Development and validation of an instrument for the determination of resistance and promotion of coping strategies in people with diabetes mellitus

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00009413

Enrollment

Registered

2016-01-27

Start date

2016-01-18

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

People with type 1 or type 2 diabetes mellitus E10 E11

Interventions

Group 1: To investigate the retest Reliablilität and interrater Reliablilität to the same patient at a time (baseline) and after four days (follow-up) of two judges, having the identical instrument (A

Eligibility

Sex/Gender

All

Age

18 Years to 67 Years

Inclusion criteria

Inclusion criteria: Patients male and female in the age of 18 to 67 years with type 1 or type 2 diabetes mellitus Patients without cognitive impairment, the medical history should in this respect be no endorsement yet German language course in spoken and written Diagnosis alone, without medical treatment or dietary management and exercise All oral diabetes medications and / or incretins insulin therapy

Exclusion criteria

Exclusion criteria: Additional diseases which impede or interfere with coping with diabetes suspected (micro- or Macroangiopathic vascular complications, tumor diseases, psychosis)

Design outcomes

Primary

Measure	Time frame
Endpoint I: assessment of the measurement instrument AWiDia (Assessment to determination resistance by people with diabetes ) The Instrument should be examined with the classical test theory, in terms of its quality, to the characteristics of reliability, validity and objectivity. The results of the individual items are described by mean and standard deviation. Endpoint II: Investigation of resistance In addition to validating the instrument, data on the patient characteristics and the resistance of the entire group should be described by methods of descriptive statistics.	—

Measure

Time frame

Endpoint I: assessment of the measurement instrument AWiDia (Assessment to determination resistance by people with diabetes ) The Instrument should be examined with the classical test theory, in terms of its quality, to the characteristics of reliability, validity and objectivity. The results of the individual items are described by mean and standard deviation. Endpoint II: Investigation of resistance In addition to validating the instrument, data on the patient characteristics and the resistance of the entire group should be described by methods of descriptive statistics.

—

Secondary

Measure	Time frame
From when the instrument measures what it should be measuring. Decisive are the individual items: Seven Punkte Likert scale: The points 1-3 = no resistance, 4 = neutral, 5-7 Resistance to this Item present.	—

Countries

Germany

Contacts

Public ContactAndrea Müller

Frankfurt University of Appied Sciences & Klinikum Fürth

andrea.s.e.mueller@googlemail.com01795934824

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026